Dialog Medical Announces New Contract With University of Miami Miller School of Medicine
Posted on: Monday, 26 February 2007, 09:01 CST
Dialog Medical, the leading provider of informed consent and patient education systems for hospitals and physician practices, today announced a new contract for its iMedConsent application with University of Miami Leonard M. Miller School of Medicine. Installation and integration of the informed consent application at the Bascom Palmer Eye Institute, University of Miami Sylvester Comprehensive Cancer Center, and other University of Miami institutes and clinics will begin this Spring.
iMedConsent includes procedure-specific consent forms for more than two thousand medical and surgical procedures; patient education documents for thousands of diagnoses and treatments; and an extensive anatomical image gallery that allows the physician to annotate images and simplify complex topics for the patient. In addition, the application automates the completion of patient documentation ranging from HIPAA disclosures to advance directives, including the digital capture of signatures, paperless storage of signed documents and electronic notation in the patient's medical record.
"We look to the iMedConsent application to help our organization enhance its processes and assist our physicians with today's challenges associated with paperwork and compliance," said Elizabeth Rockowitz, Executive Director of University of Miami Clinical Enterprise Technologies. "In addition, as we move into a more robust digital environment, this product will support the clinical workflow and transformation of clinical data available to the physician."
"This software tool is going to allow us to do more accurate and procedure-specific informed consent," stated David Arnold, M.D., Assistant Professor of Otolaryngology and Head and Neck Surgery at the University of Miami Miller School of Medicine and member of the Head and Neck Cancer Site Disease Group at UM/Sylvester. "We look forward to the iMedConsent application improving the entire consent process for our clinical staff and for our patients."
"An effective, well-documented informed consent process is essential to ensuring patient safety and is a process that can be further enhanced via automation and integration with an electronic medical record," said Michael Burke, president of Dialog Medical. "We look forward to working with the Miller School of Medicine -- an institution with a national reputation for providing outstanding health care in a multitude of clinical specialties."
About Dialog Medical
Dialog Medical is a leading provider of informed consent and patient education systems for hospitals and physician practices. The company's iMedConsent™ application is currently used by more than 15,000 physicians in hospitals and physician practices nationwide. For more information on Dialog Medical and its products, visit www.dialogmedical.com.
About University of Miami/Bascom Palmer Eye Institute
Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine is ranked the #1 eye hospital in the nation by U.S. News & World Report. Having earned an international reputation as one of the premier providers of eye care in the world, Bascom Palmer is also ranked #1 in patient care and residency training by Ophthalmology Times. As the largest ophthalmic care, research and educational center in the southeastern United States, more than 200,000 patients with nearly every ophthalmic condition are treated each year and more than 10,000 surgeries are performed annually. Founded in 1962, Bascom Palmer has patient care facilities in Miami, Palm Beach Gardens, Naples, and Plantation, Florida. Visit www.bascompalmer.org.
About University of Miami/Sylvester Comprehensive Cancer Center
UM/Sylvester opened in 1992 to provide comprehensive cancer services and today serves as the hub for cancer-related research, diagnosis, and treatment at the University of Miami Leonard M. Miller School of Medicine. UM/Sylvester handles 1,400 inpatient admissions annually, performs 3,000 surgical procedures, and treats 3,000 new cancer patients. All UM/Sylvester physicians are on the faculty of the Miller School of Medicine, South Florida's only academic medical center. In addition, UM/Sylvester physicians and scientists are engaged in 200 clinical trials and receive more than $31 million annually in research grants. UM/Sylvester at Deerfield Beach opened in 2003 to better meet the needs of residents of Broward and Palm Beach Counties. This 10,000 square-foot facility at I-95 and S.W. 10th Street offers appointments with physicians from six cancer specialties, complementary therapies from the Courtelis Center, and education and outreach events. Visit www.sylvester.org.
Source: Business Wire
Related Articles
- EMD Serono, Inc. and The University of Texas M. D. Anderson Cancer Center Announce Collaboration for Preclinical Research, Clinical Trials
- Wake Forest University Baptist Medical Center Ramps Up Cancer Treatment Capabilities With Stereotactic Systems From Elekta
- University Cardiovascular Medical Group Takes Patient Experience to Heart at the California Health & Longevity Institute
- BSD Medical's Patient Website Now Averaging Over 4,000 Hits Per Day
- The University of New Mexico Cancer Center, the Official Cancer Center of the State of New Mexico, Breaks Ground on New World-Class Cancer Treatment Center
- Wake Forest University Baptist Medical Center Adopts Single-CEO Structure
- The University of New Mexico Cancer Center, New Mexico's Official Cancer Center, Opens a New Facility in Las Cruces
- Setting the Benchmark in Brain Tumor Treatment at The University of Texas M. D. Anderson Cancer Center
- Cardinal Health Signs Agreement With the University of Texas M.D. Anderson Cancer Center for Its Alaris(R) System
- TyRx Pharma, Inc., Announces the Signing of Exclusive License Agreement With Baylor College of Medicine and The University of Texas M. D. Anderson Cancer Center
 |
 |
User Comments (0)
RSS Feeds